This report contains market size and forecasts of Viral Vector Manufacturing Services in Global, including the following market information:
Global Viral Vector Manufacturing Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Viral Vector Manufacturing Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Retroviral Vectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral Vector Manufacturing Services include Novasep, Lonza Pharma & Biotech, ABL, Inc., Takara Bio, Sartorius, Cobra Biologics, Finvector, Fujifilm Diosynth Biotechnologies and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral Vector Manufacturing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vector Manufacturing Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Viral Vector Manufacturing Services Market Segment Percentages, by Type, 2021 (%)
Retroviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Other Viral Vectors
Global Viral Vector Manufacturing Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Viral Vector Manufacturing Services Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical and Biopharmaceutical Companies
Research Institutes
Global Viral Vector Manufacturing Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Viral Vector Manufacturing Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vector Manufacturing Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Viral Vector Manufacturing Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novasep
Lonza Pharma & Biotech
ABL, Inc.
Takara Bio
Sartorius
Cobra Biologics
Finvector
Fujifilm Diosynth Biotechnologies
Sanofi
Spark Therapeutics
uniQure